eMedicine Specialties > Emergency Medicine > Cardiovascular
Torsade de Pointes: Multimedia
Updated: Aug 4, 2008
Multimedia
![]() | Media file 2: A patient with prolonged QT and atrial ectopy. Strip shows premature beat that entrains and a run of torsade de pointes. |
More on Torsade de Pointes |
| Overview: Torsade de Pointes |
| Differential Diagnoses & Workup: Torsade de Pointes |
| Treatment & Medication: Torsade de Pointes |
| Follow-up: Torsade de Pointes |
Multimedia: Torsade de Pointes |
| References |
| « Previous Page |
References
Antzelevitch C. Brugada syndrome. Pacing Clin Electrophysiol. Oct 2006;29(10):1130-59. [Medline].
Brady W, Meldon S, DeBehnke D. Comparison of prehospital monomorphic and polymorphic ventricular tachycardia: prevalence, response to therapy, and outcome. Ann Emerg Med. Jan 1995;25(1):64-70. [Medline].
Brady WJ, DeBehnke DJ, Laundrie D. Prevalence, therapeutic response, and outcome of ventricular tachycardia in the out-of-hospital setting: a comparison of monomorphic ventricular tachycardia, polymorphic ventricular tachycardia, and torsades de pointes. Acad Emerg Med. Jun 1999;6(6):609-17. [Medline].
Chen CY, Wang FL, Lin CC. Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia. Clin Toxicol (Phila). 2006;44(2):173-5. [Medline].
Delbridge TR, Yealy DM. Wide complex tachycardia. Emerg Med Clin North Am. Nov 1995;13(4):903-24. [Medline].
Dobesh PP, Trujillo TC. Ranolazine: a new option in the management of chronic stable angina. Pharmacotherapy. Dec 2007;27(12):1659-76. [Medline].
Fantoni M, Autore C, Del Borgo C. Drugs and cardiotoxicity in HIV and AIDS. Ann NY Acad Sci. 2001;946:179-99. [Medline].
Fung AY, Kerr CR, Maybee TK. QT prolongation and torsades de pointes: the sole manifestation of coronary artery disease. Int J Cardiol. Jan 1985;7(1):63-6. [Medline].
Jackson CW, Sheehan AH, Reddan JG. Evidence-based review of the black-box warning for droperidol. Am J Health Syst Pharm. Jun 1 2007;64(11):1174-86. [Medline].
Janeira LF. Torsades de pointes and long QT syndromes. Am Fam Physician. Oct 1995;52(5):1447-53. [Medline].
Kerr CR, Hacking A, Henning H. Effects of transient myocardial ischemia on the QT interval in man. Can J Cardiol. Nov-Dec 1987;3(8):383-6. [Medline].
Kerr CR, Klein GJ, Cooper JA, Sharma AD. Use of electrical pacemakers in the treatment of ventricular tachycardia and ventricular fibrillation. Cardiovasc Clin. 1985;16(1):215-37. [Medline].
Monraba R, Sala C. Percutaneous overdrive pacing in the out-of-hospital treatment of torsades de pointes [letter]. Ann Emerg Med. Mar 1999;33(3):356-7. [Medline].
Myerburg RJ, Interian A Jr, Mitrani RM, et al. Frequency of sudden cardiac death and profiles of risk. Am J Cardiol. Sep 11 1997;80(5B):10F-19F. [Medline].
Nordin C, Kohli A, Beca S. Importance of hepatitis C coinfection in the development of QT prolongation in HIV-infected patients. J Electrocardiol. Apr 2006;39(2):199-205. [Medline].
Poelzing S, Rosenbaum DS. Cellular mechanisms of Torsade de Pointes. Novartis Found Symp. 2005;266:204-17; discussion 217-24. [Medline].
Roden DM. A practical approach to torsade de pointes. Clin Cardiol. Mar 1997;20(3):285-90. [Medline].
Roden DM. Taking the "idio" out of "idiosyncratic": predicting torsades de pointes. Pacing Clin Electrophysiol. May 1998;21(5):1029-34. [Medline].
Roden DM, Anderson ME. The pause that refreshes, or does it? Mechanisms in torsades de pointes [editorial]. Heart. Sep 2000;84(3):235-7. [Medline].
Roden DM, Viswanathan PC. Genetics of acquired long QT syndrome. J Clin Invest. Aug 2005;115(8):2025-32. [Medline].
Schenck JB, Rizvi AA, Lin T. Severe primary hypothyroidism manifesting with torsades de pointes. Am J Med Sci. Mar 2006;331(3):154-6. [Medline].
Sticherling C, Schaer BA, Ammann P. Methadone-induced Torsade de pointes tachycardias. Swiss Med Wkly. May 14 2005;135(19-20):282-5. [Medline].
Tan HL, Hou CJ, Lauer MR, Sung RJ. Electrophysiologic mechanisms of the long QT interval syndromes and torsade de pointes. Ann Intern Med. May 1 1995;122(9):701-14. [Medline].
Tatetsu H, Asou N, Nakamura M. Torsades de pointes upon fluconazole administration in a patient with acute myeloblastic leukemia. Am J Hematol. Apr 20 2006;81(5):366-369. [Medline].
Viskin S, Fish R. Prevention of ventricular arrhythmias in the congenital long QT syndrome [In Process Citation]. Curr Cardiol Rep. Nov 2000;2(6):492-7. [Medline].
Viskin S, Glikson M, Fish R, et al. Rate smoothing with cardiac pacing for preventing torsade de pointes. Am J Cardiol. Nov 2 2000;86(9A):111K-115K. [Medline].
Vodoz JF, Jaquier F, Lamy O. [Torsade de pointes: a severe and unknown adverse effect in a patient taking methadone]. Schweiz Rundsch Med Prax. Oct 8 2003;92(41):1748-50. [Medline].
Vukmir RB. Torsades de Pointes: a review. Am J Emerg Med. May 1991;9(3):250-5. [Medline].
Wang SH, Lin CY, Huang TY. QT interval effects of cisapride in the clinical setting. Int J Cardiol. 2001;80 (2-3):179-83. [Medline].
Wisialowski TA, Crimin KS, Engtrakul J. Differentiation of arrhythmia risk of the antibacterials moxifloxacin, erythromycin and telithromycin based on analysis of MAPD alternans and cardiac instability. J Pharmacol Exp Ther. Apr 13 2006;[Medline].
Witchel HJ, Hancox JC. Familial and acquired long qt syndrome and the cardiac rapid delayed rectifier potassium current. Clin Exp Pharmacol Physiol. Oct 2000;27(10):753-66. [Medline].
Yearly DM, Stapcynshi JS. Dysrhythmias. In: Rosen P, Barkin RM, Braen GR, eds. Emergency Medicine: Concepts and Clinical Practice. 3rd ed. Mosby-Year Book; 1992.
Further Reading
Keywords
torsade de pointes, TDP, torsade, ventricular tachycardia, VT, polymorphous VT, twisting of the point, cardiac syncope, vasovagal syncope, QT syndrome, QT interval, sudden death, unstable heart beat rhythm, TDP rhythm, dysrhythmia, Brugada syndrome




Multimedia: Torsade de Pointes